Biomaterials

ARS POSITION STATEMENT ON BIOMATERIALS
Jan. 24,2014

The American Rhinologic Society endorses the utilization of FDA approved biomaterials, which includes implants as well as stents or packing materials used to reduce complications and improve outcomes of sinonasal surgical procedures. These biomaterials may have local drug delivery and/or stenting properties, may provide hemostasis or act as a surgical dressing, amongst other potential functions. FDA approved biomaterials for rhinologic application should not be considered investigational and the final decision regarding use of these biomaterials should be the responsibility of the treating physician, factoring in best available scientific evidence and individual patient preference.



Revised 01/24/2014
©American Rhinologic Society